Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

Even if you you’re not diabetic or obese, can Ozempic be right for you? Ever since the weekly injectable was approved in 2017 ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...